Prevalence and risk factors of chronic kidney disease in the comprehensive care program DiabetIMSS
Main Article Content
Keywords
Kidney Diseases, Renal Insufficiency, Chronic, National Health Programs
Abstract
Background: The aim of this paper is to determine prevalence and risk factors of chronic kidney disease (CKD) in the comprehensive care program DiabetIMSS.
Methods: Cross-sectional study in 488 patients with type 2 diabetes mellitus (DM2) included in the program DiabetIMSS. Sociodemographic, clinical, biochemical, and kidney function variables were collected.
Results: Prevalence of CKD was 32% [early nephropathy (EN) 19% and overt nephropathy (ON) 13%]. Patients with more severe nephropathy significantly (p < 0.05) had: older age [normal kidney function (NKF) 54±11, EN 54±10, ON 63±9, years)], cardiovascular disease (NKF 1%, EN 5%, ON 11%), hypertension (NKF 65%, EN 63%, ON 85%), longer duration of DM2 (NKF 5%, EN 5%, ON 9%,) and of hypertension (NKF 5%, EN 6%, ON 9%), glycemic lack of control (NKF 46%, EN 62%, ON 60%), hyperuricemia (NKF 7%, EN 13%, ON 23%), anemia (NKF 1%, EN 4%, ON 10%) and metabolic syndrome (NKF 79%, EN 82%, ON 93%). Uncontrolled hypertension and DM2, cardiovascular disease and hyperuricemia significantly predicted the presence of nephropathy.
Conclusions: A third of patients attending to DiabetIMSS had CKD and has not been previously diagnosed. Multiple risk factors are present in this high-risk population; their identification and control are extraordinarily important. Moreover, educative interventions for primary health-care professionals to improve health of this kind of patients are needed.
References
Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW et al. Clinical Guidelines National Kidney Foundation Practice Guidelines for Chronic Kidney. Ann Intern Med. 2003;139:137-47.
National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Clasification and Stratification. American Journal of Kidney Diseases. 2002;39(1):S1-S266.
Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ, Eckardt KU et al. Chronic kidney disease as a global public health problem: approaches and initiatives - A position statement from Kidney Disease Improving Global Outcomes. Kidney Int. 2007;72:247-59.
Group KDIGO (KDIGO) CW. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl. 2013;3(1):136-50.
The United States Renal Data System (USRDS). 2016 Annual Data Report. Ann Arbor, Michigan: The United States Renal Data System; 2016. Disponible en: http://www.usrds.org
Schieppati A, Remuzzi G. Chronic renal diseases as a public health problem: Epidemiology, social, and economic implications. Kidney Int. 2005;68(s98):S7-10.
Barsoum RS. Chronic Kidney Disease in the Developing World. N Engl J Med. 2006;354(10):997-9.
Levey AS, Andreoli SP, DuBose T, Provenzano R, Collins AJ. Chronic kidney disease: Common, harmful and treatable - World Kidney Day 2007. Am J Kidney Dis. 2007;49(2):175-97.
Amato D, Alvarez-Aguilar C, Castaneda-Limones R, Rodriguez E, Ávila-Díaz M, Arreola F et al. Prevalence of chronic kidney disease in an urban Mexican population. Kidney Int Suppl. 2005;68(97):S11-7.
Cueto-Manzano AM, Cortes-Sanabria L, MartinezRamirez HR, Rojas-Campos E, Barragan G, Alfaro G et al. Detection of early nephropathy in Mexican patients with type 2 diabetes mellitus. Kidney Int Suppl. 2005;68(97):S40-5.
Martínez-Ramírez HR, Cortés-Sanabria L, RojasCampos E, Barragán G, Alfaro G, Hernández M et al. How frequently the clinical practice recommendations for nephropathy are achieved in patients with type 2 diabetes mellitus in a primary health-care setting? Rev Invest Clin. 2008;60(3):217-26.
Nissenson AR, Collins AJ, Hurley J, Petersen H, Pereira BJ, Steinberg EP. Opportunities for improving the care of patients with chronic renal insufficiency: current practice patterns. J Am Soc Nephrol. 2001;12(8):1713-20.
Secretaría de Salud. Guía de Práctica Clínica Prevención, Diagnóstico y Tratamiento de la Enfermedad Renal Crónica Temprana Evidencias y Recomendaciones. México: Secretaría de Salud; 2009;1-96.
Cueto-Manzano AM, Martinez-Ramirez HR, Cortes-Sanabria L. Management of chronic kidney disease: primary health-care setting, self-care and multidisciplinary approach. Clin Nephrol. 2010;74:99-104.
Cueto-Manzano AM, Martínez-Ramírez HR, CortésSanabria L. Comparison of primary health-care models in the management of chronic kidney disease. Kidney Int Suppl. 2013;3(2):210-4.
Instituto Mexicano del Seguro Social. Guía técnica para otorgar atención médica en el módulo DiabetIMSS a derechohabientes con diagnóstico de diabetes mellitus tipo 2, en Unidades de Medicina Familiar. Ciudad de México: Instituto Mexicano del Seguro Social; 2013.
American Diabetes Asociation. Standards of Medical Care in Diabetes - 2016. Diabetes Care. 2016;39:S1-112.
Instituto Mexicano del Seguro Social. Informe al ejecutivo federal y al congreso de la unión sobre la situación financiera y los riesgos del Instituto Mexicano del Seguro Social 2014-2015. Ciudad de México: Instituto Mexicano del Seguro Social; 2015. 341 pp.
Instituto Nacional de Salud Pública. Encuesta Nacional de Salud y Nutrición (ENSANUT-2012), Resultados Nacionales. Instituto Nacional de Salud Pública. Cuernavaca, Morelos: Instituto Nacional de Salud Pública; 2016. Disponible en: http://ensanut.insp.mx/informes/ ENSANUT2012ResultadosNacionales.pdf
Gall M, Rossing P, Skott P, Damsbo PI, Vaag A, Bech K et al. Prevalence of micro and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulin-dependent) diabetic patients. Diabetologia. 1991;655-61.
Obrador GT, García-García G, Villa AR, Rubilar X, Olvera N, Ferreira E et al. Prevalence of chronic kidney disease in the Kidney Early Evaluation Program (KEEP) México and comparison with KEEP US. Kidney Int Suppl. 2010;77(116):S2-8.
González-Villalpando C, Stern MP, ArredondoPérez B, Martínez-Díaz S, Islas-Andrade S, Revilla C et al. Nephropathy in low income diabetics: the Mexico City Diabetes Study. Arch Med Res. 1996;27(3):367-72.
Gall MA, Hougaard P, Borch-Johnsen K, Parving HH. Risk Factors for development of incipient and over diabetic nephropathy in patients with noninsulin dependent diabetes mellitus: prospective, observational study. BMJ. 1997;314(7083):783-8.
Ravid M, Brosh D, Ravid-Safran D, Levy Z, Rachmani R. Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia. Arch Intern Med. 1998;158(9):998-1004.
Instituto Nacional de Estadística y Geografía. México en Cifras. Información Nacional, por Entidad y Municipios. Ciudad de México: Instituto Nacional de Estadística y Geografía; 2016. Disponible en: http://www3.inegi.org.mx/sistemas/mexicocifras/ default.aspx
McCulloch CE, Hsu C. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;1296-305.
Ismail N, Becker B, Strzelczyk P, Ritz E. Renal disease and hypertension in non-insulin-dependent diabetes mellitus. Kidney Int. 1999;55(1):1-28.
Aguilar-Salinas C, Velázquez-Monrroy O, Gómez-Pérez F. Characteristics of patients with Type 2 Diabetes in México. Diabetes Care. 2003;26(7):2021-6.
Liu WC, Hung CC, Chen SC, Yeh SM, Lin MY, Chiu YW et al. Association of hyperuricemia with renal outcomes, cardiovascular disease, and mortality. Clin J Am Soc Nephrol. 2012;7(4):541-8.